CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 9.39
+0.06 (0.64%)
Sep 28, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of 107.2 billion as of September 28, 2026. Its market cap has increased by 3.15% in one year.
Market Cap
107.20B
Enterprise Value
88.77B
Revenue
36.17B
Ranking
n/a
PE Ratio
12.50
Stock Price
9.39
ChartMarket Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 696.00M to 107.20B, an increase of 15,301.82%. That is a compound annual growth rate of 17.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 107.20B | 11.22% |
| Dec 31, 2025 | 96.38B | 74.70% |
| Dec 31, 2024 | 55.17B | -35.87% |
| Dec 29, 2023 | 86.02B | -11.96% |
| Dec 30, 2022 | 97.71B | -3.19% |
| Dec 31, 2021 | 100.93B | 6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 321.84B |
| WuXi Biologics | 217.50B |
| Hansoh Pharmaceutical Group Company | 203.22B |
| Innovent Biologics | 173.57B |
| JD Health International | 111.89B |
| Sichuan Kelun-Biotech Biopharmaceutical | 111.62B |
| WuXi XDC Cayman | 102.58B |
| Sino Biopharmaceutical | 99.18B |